Feature | July 14, 2011| Dave Fornell

Key Points in Carotid Stenting

Patient selection, technique, imaging and experience are required

Carotid stenting is a more complex and challenging procedure than coronaries or peripheral vessels. Carotid stenting experts have the following advice for hospitals and physicians that want to enter this market.


Patient Selection  
Patient selection is a major concern when it comes to carotid stenting.  Many trials focus on the most complex cases in some of the sickest patients, and many times these patients have several co-morbidities, said Sriram Iyer, M.D., FACC, associate chairman, Heart and Vascular Institute, Lenox Hill Hospital, N.Y.  Many times these patients also have left main coronary artery disease, aortic stenosis and renal dysfunction, among other problems. His recommendation is to keep procedures as simple as possible by using careful patient selection.  


“Avoid these complicated patients and keep it simple,” he explains. This will lead to fewer complications.
He said the most critical part of carotid cases is accessing the carotid arteries via the aortic arch. “The two important things you need are speed and minimal manipulation, because at this time you have no embolic protection,” Iyer said.  However, MRI or CT imaging plays a big role in being able to select patients who do not have heavy “popcorn” plaque in their aortic arch or heavy plaque burden and tortuous vessels leading into the carotids, which might make stenting a less attractive option because of the stroke risk.


Pre-Procedure Imaging
Ultrasound, MRI or CT imaging is needed to screen patients to see if they are good candidates for stenting. Some circumstances that might make physicians think twice about transcatheter interventions include extremely sharp bends in the vessel, which will likely cause emboli as wires are pushed through the vessel before an embolic protection device (EPD) can be deployed. EPDs are required for carotid stenting reimbursement from the Centers of Medicare and Medicaid Services (CMS).


Techniques
From his experience, Iyer offers the following helpful techniques for carotid stenting:
• Pre-dilatation of the vessel with a 2-2.5 mm coronary balloon to aid in the deployment of the EPD.
• EPDs generally do not offer complete vessel wall apposition in bends.
• Use a buddy wire to help straighten the vessel to deliver the EPD and to secure the vessel.
• Use a Judkins Right catheter to help support and enter the carotid side branch.
• If the anatomy of the occlusion is in a
bend, use an open-cell design stent because they bend easier.
• EPD dwell time should be less than seven minutes, because after that time fibrin quickly accumulates and clots the filter.
• Move the patient’s head to help rotate vessels in the neck.
• Ideal lesions to stent are those in straight segments of the vessel.


Barry Katzen, M.D., FSIR, medical director of Baptist Cardiac and Vascular Institute and clinical professor of radiology at the University of Miami School of Medicine, Miami, Fla., also suggests using Doppler ultrasound of the carotid artery to measure flow velocity prior to and following stenting.


Complications of Carotid Stenting
Carotid stenting studies between 2000 and 2008 showed major adverse coronary and cerebral events (MACCE) rates dropped from 8.3 percent down to 2.3 percent, mainly because operators became more experienced as time went on, said Daniel McCormick, D.O., director, cardiac catheterization laboratory at Hahnemann University Hospital, Philadelphia. “The second half of the CREST trial had a significant decrease in complications and that is all about the experience level of the operators improving,” McCormick said. “You really need to know when to quit when things are not going well.”


Katzen agreed, saying, “There has been a major improvement in patient outcomes in each of these trials. This is due to better techniques and increased operator experience...Stents will protect patients against stroke just as well as surgery.”
However, Katzen said operators need to be highly experienced to keep complications to a minimum. He advocates for only a limited number of operators at higher-volume facilities to serve as the carotid stenting experts.


McCormick said some of the complications operators may encounter include:
• Post stenting bradycardia/hypotension, caused by balloon pressures on carotid baroreceptors.
• Atropine-induced confusion in elderly patients, which complicates post-procedure neurological assessments.
• Cerebral hemorrhage is rare, but usually fatal. If suspected, the procedure needs to be terminated, reverse heparin and conduct an emergency CT scan.
• Carotid stent thrombosis, which can be aspirated.

Related Content

Intact Vascular, TOBA clinical study, one-year results, Tack Endovascular System, Journal of Vascular Surgery
News | Peripheral Arterial Disease (PAD)| August 24, 2016
Intact Vascular Inc. announced that the one-year results from its Tack Optimized Balloon Angioplasty (TOBA) clinical...
Absorb, bioresorbable stent, FDA approval, FDA approves, FDA clears, most popular content, most popular stories, DAIC

The FDA clearance of the first bioresorbable stent, the Abbott Absorb, the first week of July has been the most popular story so far for all of 2016. It is the first fully dissolving stent approved for the U.S. market and many experts say this technology could be a paradigm shift in coronary and peripheral therapies in the coming years as the technology improves. 

Feature | August 05, 2016 | Dave Fornell
 
Abbott Absorb bioresorbable stent, dissolving BVS, first West Coast implant, Good Samaritan Hospital Los Angeles
News | Stents Bioresorbable| July 19, 2016
Good Samaritan Hospital, Los Angeles, is the first hospital on the West Coast to offer patients with coronary artery...
Abbott, Absorb bioresorbable stent, University Hospitals Case Medical Center, first Midwest implant
News | Stents Bioresorbable| July 11, 2016
University Hospitals Case Medical Center, Cleveland, is among the first in the country – and the first in Ohio — to...
Absorb, bioresorbable stent, FDA approval, FDA approves, FDA clears, dissolving stent

The Abbott Absorb is the first bioresorbable stent to be cleared for use in the United States. 

Technology | Stents Bioresorbable| July 05, 2016 | Dave Fornell
July 5, 2016 — The U.S.
News | Stents Bioresorbable| June 06, 2016
Amaranth Medical announced that it completed enrollment in May in the RENASCENT-II study of its novel Aptitude 120-...
congenital heart, pulmonary artery stenting, JACC study
News | Congenital Heart| May 31, 2016
In a recent study, the use of a stent to repair pulmonary artery stenosis in children and adults with congenital heart...
Watchman, left atrial appendage closure, LAA occluder, LAA. LAAO, laa occluder, left atrial appendage, Watchman

The Boston Scientific Watchman device is currently the only transcatheter LAA occluder cleared for use in the United States.

Feature | Left Atrial Appendage (LAA) Occluders| May 20, 2016 | Dave Fornell
Atrial fibrillation (AF) affects nearly 6 million Americans and the condition puts them at significantly greater risk
Biotronik, Magmaris bioresorbable magnesium scaffold, BIOSOLVE-II Trial, 12-month results, EuroPCR 2016
News | Stents Bioresorbable| May 17, 2016
Biotronik presented 12-month data from the BIOSOLVE-II trial during a Hotline Session at EuroPCR 2016.

Biosensors' Biomatrix stent.

Feature | Stents| May 16, 2016
May 16, 2016 — Cardinal Health announced it has entered into a distribution agreement with Biosensors that enables Co
Overlay Init